| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXSL1800003 | FPA144注射液 | bemarituzumab | Injection | Biological Products | Import Drug Application | 2018-02-06 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2018-06-04 | view |